Physician profile
Angela Mcdowell
NPI 1346442019
$861.97
in general payments reported to CMS, 2019-2025
25 companies · $18.42 in 2025
The $18.42 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $46.31 · 2021: $33.42 · 2022: $71.45 · 2023: $298 · 2024: $119 · 2025: $18.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $435.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $200.75 | 2023-2024 | Altis |
| Abbvie INC. | $132.51 | 2019-2023 | |
| Intuitive Surgical, INC. | $53.81 | 2024 | |
| Hologic Sales and Service, LLC | $42.03 | 2019-2020 | |
| Lupin INC. | $41.37 | 2019 | |
| Organon LLC | $40.47 | 2023 | Nexplanon |
| Novo Nordisk INC | $35.23 | 2019-2023 | Wegovy |
| Solventum Corporation | $34.35 | 2024-2025 | Activ.A.C., Prevena |
| Duchesnay USA Incorporated | $23.59 | 2019 | |
| Bausch Health US, LLC | $23.53 | 2022 | |
| Roche Diagnostics Corporation | $23.42 | 2019 | |
| Medtronic, INC. | $22.97 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.18 | 2023 | |
| Shield Therapeutics INC | $17.26 | 2023 | Accrufer |
| Avion Pharmaceuticals | $16.67 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $16.23 | 2024 | Bulkamid, Axonics |
| Astellas Pharma US INC | $16.07 | 2024 | Veozah |
| Takeda Pharmaceuticals U.S.A., INC. | $14.47 | 2020 | |
| Allergan, INC. | $14.12 | 2019 | |
| Shire North American Group INC | $13.91 | 2019 | |
| Dysis Medical, INC. | $12.85 | 2022 | |
| Amag Pharmaceuticals, INC. | $12.38 | 2019 | |
| Minerva Surgical, INC | $12.10 | 2022 | |
| Smith+Nephew, INC. | $11.37 | 2020 | |
| Ironwood Pharmaceuticals, INC | $11.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Mcdowell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.